IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $29,000 | +52.6% | 352 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $19,000 | +35.7% | 352 | +29.4% | 0.01% | +33.3% |
| Q3 2018 | $14,000 | +27.3% | 272 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $11,000 | -31.2% | 272 | -26.7% | 0.00% | -33.3% |
| Q1 2018 | $16,000 | -44.8% | 371 | -35.0% | 0.01% | -45.5% |
| Q4 2017 | $29,000 | -78.7% | 571 | -78.8% | 0.01% | -79.2% |
| Q3 2017 | $136,000 | +1.5% | 2,690 | +2.1% | 0.05% | -5.4% |
| Q2 2017 | $134,000 | +26.4% | 2,635 | 0.0% | 0.06% | +21.7% |
| Q1 2017 | $106,000 | -20.3% | 2,635 | -5.0% | 0.05% | -24.6% |
| Q4 2016 | $133,000 | +54.7% | 2,775 | +18.5% | 0.06% | +52.5% |
| Q3 2016 | $86,000 | +21.1% | 2,341 | -22.7% | 0.04% | +17.6% |
| Q2 2016 | $71,000 | -41.8% | 3,029 | 0.0% | 0.03% | -42.4% |
| Q1 2016 | $122,000 | -15.3% | 3,029 | +29.9% | 0.06% | -7.8% |
| Q4 2015 | $144,000 | – | 2,332 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |